320 related articles for article (PubMed ID: 34668278)
1. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
Respirology; 2022 Jan; 27(1):14-35. PubMed ID: 34668278
[TBL] [Abstract][Full Text] [Related]
2. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
[TBL] [Abstract][Full Text] [Related]
3. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
Am J Respir Crit Care Med; 2022 Jan; 205(1):17-35. PubMed ID: 34658302
[TBL] [Abstract][Full Text] [Related]
4. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
Arch Bronconeumol; 2022 Jan; 58(1):35-51. PubMed ID: 35245179
[TBL] [Abstract][Full Text] [Related]
5. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
6. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
[TBL] [Abstract][Full Text] [Related]
7. Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies.
Canonica GW; Paggiaro P; Blasi F; Musarra A; Richeldi L; Rossi A; Papi A
Ther Adv Respir Dis; 2021; 15():17534666211042534. PubMed ID: 34587829
[TBL] [Abstract][Full Text] [Related]
8. Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction-Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA.
Ozseker ZF; Aksu K; Mutlu LC; Mutlu P; Ozturk C;
Curr Allergy Asthma Rep; 2022 Oct; 22(10):123-134. PubMed ID: 35689764
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
[TBL] [Abstract][Full Text] [Related]
10. It is time to change the way we manage mild asthma: an update in GINA 2019.
Muneswarao J; Hassali MA; Ibrahim B; Saini B; Ali IAH; Verma AK
Respir Res; 2019 Aug; 20(1):183. PubMed ID: 31412856
[TBL] [Abstract][Full Text] [Related]
11. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
[TBL] [Abstract][Full Text] [Related]
12. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.
Levy ML; Bacharier LB; Bateman E; Boulet LP; Brightling C; Buhl R; Brusselle G; Cruz AA; Drazen JM; Duijts L; Fleming L; Inoue H; Ko FWS; Krishnan JA; Mortimer K; Pitrez PM; Sheikh A; Yorgancıoğlu A; Reddel HK
NPJ Prim Care Respir Med; 2023 Feb; 33(1):7. PubMed ID: 36754956
[TBL] [Abstract][Full Text] [Related]
13. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C; Rello J; Sogo A
Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
[TBL] [Abstract][Full Text] [Related]
14. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
15. The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription.
Domingo C; Singh D
Adv Ther; 2023 Apr; 40(4):1301-1316. PubMed ID: 36715896
[TBL] [Abstract][Full Text] [Related]
16. An independent in-depth analysis proposing adjusted Global Initiative on Asthma Step 1-2 treatment suggestions.
Larenas-Linnemann D; Navarrete-Rodríguez EM; Luna-Pech JA; Benítez R; Cano-Salas MC; Del Rio-Navarro BE; García-Ramírez UN; Gochicoa L; López-Estrada EDC; Ortega-Martell JA; Salas Hernández J
Clin Exp Allergy; 2022 Apr; 52(4):493-511. PubMed ID: 34904293
[TBL] [Abstract][Full Text] [Related]
17. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
18. The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem.
Kaplan A
Adv Ther; 2021 Mar; 38(3):1369-1381. PubMed ID: 33474708
[TBL] [Abstract][Full Text] [Related]
19. European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma.
Papi A; Ferreira DS; Agache I; Baraldi E; Beasley R; Brusselle G; Coleman C; Gaga M; Gotera Rivera CM; Melén E; Pavord ID; Peñate Gómez D; Schuermans D; Spanevello A; Tonia T; Schleich F
Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37678955
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β
Roche N; Yorgancıoğlu A; Cruz AA; Garcia G; Lavoie KL; Abhijith PG; Verma M; Majumdar A; Chatterjee S
Respir Med; 2024 Jan; 221():107478. PubMed ID: 38008385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
